Vasodilator Response Correlates with Outcome in Chronic Critical Limb Ischemia

被引:4
作者
Muto, Akihito [2 ,3 ]
Kondo, Yuka [2 ,3 ]
Pimiento, Jose M. [4 ]
Fitzgerald, Tamara N. [2 ,3 ]
Dardik, Alan [2 ,3 ,5 ]
Nishibe, Toshiya [1 ]
机构
[1] Eniwa Midorino Clin, Dept Surg, Eniwa, Hokkaido 0611442, Japan
[2] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT USA
[4] St Marys Hosp, Waterbury, CT USA
[5] VA Connecticut Healthcare Syst, West Haven, CT USA
关键词
skin perfusion pressure; critical limb ischemia; lipo-prostaglandin E-1; alprostadil; SKIN PERFUSION-PRESSURE; PROSTAGLANDIN E-1; INTERMITTENT CLAUDICATION; PARENTERAL THERAPY; LIPO-ECRAPROST; ANALOG; LIPO-PGE(1); DIAGNOSIS; INFUSION; FLOW;
D O I
10.1016/j.jss.2008.10.024
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. There are few predictors of limb salvage in patients with critical limb ischemia (CLI). We evaluated the accuracy of correlation of skin perfusion pressure (SPP) measurements in response to vasodilation to clinical outcome. Methods. Patients with CLI were evaluated by SPP at baseline. After injection of the vasodilator alprostadil, SPP was re-evaluated at 120 min and at day 7. Results. Patients showing clinical improvement demonstrated increased SPP in response to vasodilation (120 min: 34.12 +/- 2.44 to 48.33 +/- 3.41 mm Hg, P < 0.01; day 7: 33.13 +/- 3.14 to 45.83 +/- 3.79 mm Hg, P < 0.01), whereas patients who clinically deteriorated demonstrated no increase in SPP (120 min: 30.00 +/- 2.67 to 35.00 +/- 2.31 mm Hg, P = 0.086; day 7: 35.00 +/- 3.54 to 27.5 +/- 4.33 mm Hg, P = 0.22). Conclusions. Prognosis for limb salvage correlated with SPP improvement post-vasodilator treatment after both early and late time points. Measurement of SPP after vasodilator treatment may be clinically useful in the treatment of patients with CLI. A multi-center trial of SPP in response to vasodilators is warranted. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 20 条
[1]   PREDICTION OF AMPUTATION WOUND-HEALING WITH SKIN PERFUSION-PRESSURE [J].
ADERA, HM ;
JAMES, K ;
CASTRONUOVO, JJ ;
BYRNE, M ;
DESHMUKH, R ;
LOHR, J .
JOURNAL OF VASCULAR SURGERY, 1995, 21 (05) :823-829
[2]   Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia [J].
Brass, EP ;
Anthony, R ;
Dormandy, J ;
Hiatt, WR ;
Jiao, J ;
Nakanishi, A ;
McNamara, T ;
Nehler, M .
JOURNAL OF VASCULAR SURGERY, 2006, 43 (04) :752-759
[3]   Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia [J].
Castronuovo, JJ ;
Adera, HM ;
Smiell, JM ;
Price, RM .
JOURNAL OF VASCULAR SURGERY, 1997, 26 (04) :629-637
[4]   PULMONARY EXTRACTION AND PHARMACOKINETICS OF PROSTAGLANDIN-E1 DURING CONTINUOUS INTRAVENOUS-INFUSION IN PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROME [J].
COX, JW ;
ANDREADIS, NA ;
BONE, RC ;
MAUNDER, RJ ;
PULLEN, RH ;
URSPRUNG, JJ ;
VASSAR, MJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (01) :5-12
[5]   Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV [J].
Creutzig, A ;
Lehmacher, W ;
Elze, M .
VASA-JOURNAL OF VASCULAR DISEASES, 2004, 33 (03) :137-144
[6]   METABOLISM OF PROSTAGLANDINS-A1 AND PROSTAGLANDINS-E1 IN MAN [J].
GOLUB, M ;
ZIA, P ;
MATSUNO, M ;
HORTON, R .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (06) :1404-1410
[7]   Marked hypotensive and blood flow-increasing effects of a new lipo-PGE1 (lipo-AS013) due to vascular wall targeting [J].
Igarashi, R ;
Takenaga, M ;
Takeuchi, J ;
Kitagawa, A ;
Matsumoto, K ;
Mizushima, Y .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (02) :157-164
[8]  
Kondo Y, 2007, INT ANGIOL, V26, P258
[9]  
Lièvre M, 2000, CIRCULATION, V102, P426
[10]   Effects of prostaglandin E-1 infusion on limb hemodynamics and vasodilatory response in patients with arteriosclerosis obliterans [J].
Makita, S ;
Nakamura, M ;
Ohhira, A ;
Itoh, S ;
Hiramori, K .
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (03) :441-448